Ethic Inc’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
PL
LWAM
QCM
DC
AI
SFA
SOAM
Ethic Inc's GMAB Position: Q2 2026 in Review
Ethic Inc reduced its Genmab (GMAB) stake by 36% in Q2 2026, selling an estimated $205K and leaving 13,992 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #1036.
Ethic Inc first reported a position in GMAB in Q2 2021 and has held it in 19 quarters since. The position peaked at $684K in Q4 2022. 73 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.
- Ethic Inc held 13,992 shares of Genmab worth $384K as of Q2 2026.
- Ethic Inc sold 7,708 Genmab shares in Q2 2026, an estimated $205K.
- Genmab made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1036 holding.
- Ethic Inc first reported a position in Genmab in Q2 2021 and has held it in 19 quarters since.
- Ethic Inc's Genmab position peaked at $684K in Q4 2022.
- 73 funds tracked by Wall St. Rank held Genmab as of Q2 2026.
Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.